Average Co-Inventor Count = 6.78
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amunix Operating Inc. (21 from 24 patents)
2. Amunix Pharmaceuticals, Inc (3 from 9 patents)
3. Bioverativ Therapeutics Inc. (1 from 73 patents)
25 patents:
1. 10961287 - Extended recombinant polypeptides and compositions comprising same
2. 10953073 - XTEN conjugate compositions and methods of making same
3. 10870874 - Binding fusion proteins, binding fusion protein-drug conjugates, XTEN-drug conjugates and methods of making and using same
4. 10421798 - Factor VIII compositions and methods of making and using same
5. 10172953 - XTEN conjugate compositions and methods of making same
6. 10000543 - Glucose-regulating polypeptides and methods of making and using same
7. 9976166 - Binding fusion proteins, binding fusion protein-drug conjugates, XTEN-drug conjugates and methods of making and using same
8. 9938331 - Biologically active proteins having increased in vivo and/or in vitro stability
9. 9926351 - Extended recombinant polypeptides and compositions comprising same
10. 9849188 - Growth hormone polypeptides and methods of making and using same
11. 9758776 - Coagulation factor IX compositions and methods of making and using same
12. 9540430 - Glucose-regulating polypeptides and methods of making and using same
13. 9376672 - Coagulation factor IX compositions and methods of making and using same
14. 9371369 - Extended recombinant polypeptides and compositions comprising same
15. 9249211 - Binding fusion proteins, binding fusion protein-drug conjugates, XTEN-drug conjugates and methods of making and using same